Search Results - "Marth, K"

Combined analysis of five non-interventional studies of the effectiveness, tolerability, and safety of the extrafine fixed dose beclomethasone/formoterol combination in the treatment of asthma in Austria by Renner, A., Marth, K., Breyer-Kohansal, R., Pohl, W.

“…The real-world effectiveness and tolerability of an extrafine fixed dose beclomethasone/formoterol (BDP/FF) treatment of patients with partially or…”
Get full text

Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity by Focke, M., Swoboda, I., Marth, K., Valenta, R.

“…Summary Allergen‐specific immunotherapy (SIT) is the only specific and disease‐modifying approach for the treatment of allergy but several disadvantages have…”
Get full text

Allergen-specific immunotherapy: from therapeutic vaccines to prophylactic approaches by Valenta, R., Campana, R., Marth, K., van Hage, M.

“…  Valenta R, Campana R, Marth K, van Hage M (Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology,…”
Get full text

Heterogeneity of commercial timothy grass pollen extracts by Focke, M., Marth, K., Flicker, S., Valenta, R.

“…Summary Background The diagnosis and specific immunotherapy of allergy is currently performed with allergen extracts prepared from natural allergen sources…”
Get full text

Molecular composition and biological activity of commercial birch pollen allergen extracts by Focke, M., Marth, K., Valenta, R.

“…Background  Commercial extracts used for diagnosis and treatment of allergy are currently prepared from natural allergen sources. The aim of this study was to…”
Get full text

Hypoallergenic derivatives of Fel d 1 obtained by rational reassembly for allergy vaccination and tolerance induction by Curin, M., Weber, M., Thalhamer, T., Swoboda, I., Focke-Tejkl, M., Blatt, K., Valent, P., Marth, K., Garmatiuk, T., Grönlund, H., Thalhamer, J., Spitzauer, S., Valenta, R.

“…Summary Background and objective The major cat allergen Fel d 1 represents one of the most important respiratory allergens. Aim of this study was to engineer…”
Get full text

Isolation of a high‐affinity Bet v 1‐specific IgG‐derived ScFv from a subject vaccinated with hypoallergenic Bet v 1 fragments by Gadermaier, E., Marth, K., Lupinek, C., Campana, R., Hofer, G., Blatt, K., Smiljkovic, D., Roder, U., Focke‐Tejkl, M., Vrtala, S., Keller, W., Valent, P., Valenta, R., Flicker, S.

“…Background Recombinant hypoallergenic allergen derivatives have been used in clinical immunotherapy studies, and clinical efficacy seems to be related to the…”
Get full text

Intranasal administration of allergen increases specific IgE whereas intranasal omalizumab does not increase serum IgE levels—A pilot study by Eckl‐Dorna, J., Fröschl, R., Lupinek, C., Kiss, R., Gattinger, P., Marth, K., Campana, R., Mittermann, I., Blatt, K., Valent, P., Selb, R., Mayer, A., Gangl, K., Steiner, I., Gamper, J., Perkmann, T., Zieglmayer, P., Gevaert, P., Valenta, R., Niederberger, V.

“…Background Administration of the therapeutic anti‐IgE antibody omalizumab to patients induces strong increases in IgE antibody levels. Objective To investigate…”
Get full text

The majority of allergen-specific IgE in the blood of allergic patients does not originate from blood-derived B cells or plasma cells by Eckl-Dorna, J., Pree, I., Reisinger, J., Marth, K., Chen, K.-W., Vrtala, S., Spitzauer, S., Valenta, R., Niederberger, V.

“…Background The production of allergen‐specific IgE antibodies is a hallmark of IgE‐mediated allergy but the contribution of blood cells to allergen‐specific…”
Get full text

Recombinant allergens promote expression of aminopeptidase-n (CD13) on basophils in allergic patients by Sonneck, K, Baumgartner, C, Rebuzzi, L, Marth, K, Chen, K W, Hauswirth, A W, Florian, S, Vrtala, S, Bühring, H J, Valenta, R, Valent, P

“…IgE-dependent activation of basophils is associated with upregulation of several surface molecules. We recently identified the surface enzyme aminopeptidase N…”
Get more information

P112 Exhaled nitric oxide is a possible biomarker for predicting complications in cystic fibrosis patients by Renner, A., Kaluza, I., Marth, K., Moeslinger, T., Pohl, W.

Get full text

Human monoclonal antibody–based quantification of group 2 grass pollen allergens by Marth, Katharina, Focke, Margarete, Flicker, Sabine, Valenta, Rudolf

“…Grasses belong to the most potent allergen sources worldwide. Group 2 grass pollen allergens are recognized by more than 100 million allergic patients. The aim…”
Get full text

Enhanced electrochemical performance of O3-type NaNi0.5Mn0.3Co0.2O2 cathodes for sodium-ion batteries via Al-doping by Kumar, V. Kiran, Ghosh, Shuvajit, Ghosh, Sourav, Behera, P. Suchismita, Biswas, Sanjay, Martha, Surendra K.

“…O3-type NaNi0.5Mn0.3Co0.2O2 based positive electrode materials are very promising for sodium-ion batteries. However, the irreversible phase transition due to…”
Get full text

Automated Code Generation for Industrial-Strength Systems by Weigert, T., Weil, F., van den Berg, A., Dietz, P., Marth, K.

“…Model-driven engineering proposes to develop software systems by first creating an executable model of the system design and then transforming this model into…”
Get full text